What did @cammident actually say?
Honestly, this is a difficult video to fact-check because the available transcript is largely incoherent. The auto-generated captions produced phrases like "a team of apostles" and "confidence from LaDellia" that appear to be mistranslations or transcription errors from what was likely a Spanish-language video, given the hashtags diabetes and resistenciaainsulina (insulin resistance). What we can reasonably infer is that @cammident was sharing a personal experience with Ozempic, specifically in the context of diabetes and insulin resistance. The creator references taking instructions, going to the gym, and feeling prepared, suggesting a lifestyle-plus-medication narrative. Without a clean transcript, we cannot quote specific medical claims directly. What we can do is evaluate the broader framework that Ozempic-for-insulin-resistance videos on TikTok typically present, and flag where creators in this category frequently get things wrong.
Does the science back up the general premise?
Using semaglutide (the active ingredient in Ozempic) for insulin resistance in the context of type 2 diabetes? Yes, that part has solid evidence behind it. The connection between GLP-1 receptor agonists and improved insulin sensitivity is well-documented. Semaglutide works by mimicking glucagon-like peptide-1, which stimulates insulin secretion in a glucose-dependent way, meaning it doesn't push insulin release when blood sugar is already low. The SUSTAIN clinical trial program, summarized by Sorli et al. (2017, The Lancet Diabetes and Endocrinology), demonstrated significant HbA1c reductions across multiple patient populations. Marso et al. (2016, New England Journal of Medicine, the LEADER trial's semaglutide counterpart SUSTAIN-6) also showed cardiovascular benefits in high-risk type 2 diabetes patients. So the premise that Ozempic can help people managing diabetes and insulin resistance is not fringe content. It's mainstream endocrinology. The problem is usually in the details, not the big picture.
What did they get wrong, or right?
Without a clean transcript, we can't pin specific errors on this creator. That matters. Attributing inaccuracies to someone based on garbled auto-captions would itself be bad journalism. What we can say is that the framing, a personal testimonial about Ozempic combined with gym and lifestyle references, reflects a pattern common in this content category. That pattern sometimes gets things right: exercise does improve GLP-1 drug outcomes. Biagetti et al. (2021, Diabetes Research and Clinical Practice) found that combining semaglutide with structured physical activity produced better glycemic control than medication alone. Where creators in this category typically go wrong is suggesting Ozempic treats insulin resistance as a standalone condition separate from a broader metabolic management plan, or implying the drug alone drives results. The gym reference here, if that's genuinely what was said, is actually the right instinct. Ozempic is not a substitute for lifestyle changes. It works better alongside them.
What should you actually know?
Ozempic is FDA-approved specifically for type 2 diabetes management, not as a general insulin resistance treatment. Insulin resistance exists on a spectrum, and not everyone with it has type 2 diabetes or qualifies for semaglutide. If you watched this video hoping it gives you a roadmap for self-treating insulin resistance with Ozempic, pump the brakes. Dosing, eligibility, and whether semaglutide is even the right drug for your situation requires an actual clinical evaluation. Side effects are real: nausea and gastrointestinal issues affect a meaningful portion of users. Davies et al. (2021, Diabetes Care) reported GI adverse events in roughly 30-40% of participants in semaglutide trials. There is also ongoing regulatory scrutiny around compounded semaglutide products, which are not equivalent to brand-name Ozempic or Wegovy. Anyone pointing you toward compounded versions as a cheaper identical swap is either misinformed or not being straight with you. Speak to a licensed provider who can actually review your labs before starting any GLP-1 therapy.